EXECUTIVE ENGAGEMENTS
OUTREACH
INTERACTIONS
PARTICIPANTS
VALIDATIONS
COMPETITORS
BRANDS
* Login for a full stack data experience
DATE
JUL 2020
TABLES
117
PAGES
312
EDITION
17
PRICE
USD $5450
HIGHLIGHTS
SELECT PLAYERS
Biogen, Inc.; Boehringer Ingelheim GmbH; Daiichi Sankyo Co., Ltd.; Eisai Co., Ltd.; F. Hoffmann-La Roche AG; GlaxoSmithKline PLC; H. Lundbeck A/S; Merck KGaA; Mitsubishi Tanabe Pharma Corporation; Novartis International AG; Pfizer, Inc.; Reata Pharmaceuticals, Inc.; Sage Therapeutics, Inc.; Sanofi; Teva Pharmaceutical Industries Ltd.; UCB SA
SEGMENTS
» Indication Drug (Parkinsons Disease, Huntington Disease, Amyotrophic Lateral Sclerosis, Alzheimers Disease, and Other Indication Drugs)
GEOGRAPHIES
» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » Spain » Russia » and Rest of Europe » Asia-Pacific » Australia » India » South Korea » and Rest of Asia-Pacific » Latin America » Argentina » Brazil » Mexico » and Rest of Latin America » Middle East » Iran » Israel » Saudi Arabia » United Arab Emirates » and Rest of Middle East » and Africa
TABLE OF CONTENTS
I. INTRODUCTION, METHODOLOGY & REPORT SCOPE |
II. EXECUTIVE SUMMARY |
1. MARKET OVERVIEW |
Global Competitor Market Shares |
Neurodegenerative Drugs Competitor Market Share Scenario Worldwide (in %): 2019 & 2028 |
Impact of Covid-19 and a Looming Global Recession |
2. FOCUS ON SELECT PLAYERS |
3. MARKET TRENDS & DRIVERS |
4. GLOBAL MARKET PERSPECTIVE |
Neurodegenerative Drugs Global Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025 |
Neurodegenerative Drugs Global Retrospective Market Scenario in US$ Million by Region/Country: 2009-2017 |
Neurodegenerative Drugs Market Share Shift across Key Geographies Worldwide: 2009 VS 2019 VS 2025 |
Parkinsons Disease (Indication Drug) World Market by Region/Country in US$ Million: 2018 to 2025 |
Parkinsons Disease (Indication Drug) Historic Market Analysis by Region/Country in US$ Million: 2009 to 2017 |
Parkinsons Disease (Indication Drug) Market Share Breakdown of Worldwide Sales by Region/Country: 2009 VS 2019 VS 2025 |
Huntington Disease (Indication Drug) Potential Growth Markets Worldwide in US$ Million: 2018 to 2025 |
Huntington Disease (Indication Drug) Historic Market Perspective by Region/Country in US$ Million: 2009 to 2017 |
Huntington Disease (Indication Drug) Market Sales Breakdown by Region/Country in Percentage: 2009 VS 2019 VS 2025 |
Amyotrophic Lateral Sclerosis (Indication Drug) Geographic Market Spread Worldwide in US$ Million: 2018 to 2025 |
Amyotrophic Lateral Sclerosis (Indication Drug) Region Wise Breakdown of Global Historic Demand in US$ Million: 2009 to 2017 |
Amyotrophic Lateral Sclerosis (Indication Drug) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025 |
Alzheimers Disease (Indication Drug) World Market Estimates and Forecasts by Region/Country in US$ Million: 2018 to 2025 |
Alzheimers Disease (Indication Drug) Market Historic Review by Region/Country in US$ Million: 2009 to 2017 |
Alzheimers Disease (Indication Drug) Market Share Breakdown by Region/Country: 2009 VS 2019 VS 2025 |
Other Indication Drugs (Indication Drug) World Market by Region/Country in US$ Million: 2018 to 2025 |
Other Indication Drugs (Indication Drug) Historic Market Analysis by Region/Country in US$ Million: 2009 to 2017 |
Other Indication Drugs (Indication Drug) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025 |
III. MARKET ANALYSIS |
GEOGRAPHIC MARKET ANALYSIS |
United States |
Market Facts & Figures |
US Neurodegenerative Drugs Market Share (in %) by Company: 2019 & 2025 |
United States Neurodegenerative Drugs Market Estimates and Projections in US$ Million by Indication Drug: 2018 to 2025 |
Neurodegenerative Drugs Market in the United States by Indication Drug: A Historic Review in US$ Million for 2009-2017 |
United States Neurodegenerative Drugs Market Share Breakdown by Indication Drug: 2009 VS 2019 VS 2025 |
Canada |
Canadian Neurodegenerative Drugs Market Estimates and Forecasts in US$ Million by Indication Drug: 2018 to 2025 |
Canadian Neurodegenerative Drugs Historic Market Review by Indication Drug in US$ Million: 2009-2017 |
Neurodegenerative Drugs Market in Canada: Percentage Share Breakdown of Sales by Indication Drug for 2009, 2019, and 2025 |
Japan |
Japanese Market for Neurodegenerative Drugs: Annual Sales Estimates and Projections in US$ Million by Indication Drug for the Period 2018-2025 |
Neurodegenerative Drugs Market in Japan: Historic Sales Analysis in US$ Million by Indication Drug for the Period 2009-2017 |
Japanese Neurodegenerative Drugs Market Share Analysis by Indication Drug: 2009 VS 2019 VS 2025 |
China |
Chinese Neurodegenerative Drugs Market Growth Prospects in US$ Million by Indication Drug for the Period 2018-2025 |
Neurodegenerative Drugs Historic Market Analysis in China in US$ Million by Indication Drug: 2009-2017 |
Chinese Neurodegenerative Drugs Market by Indication Drug: Percentage Breakdown of Sales for 2009, 2019, and 2025 |
Europe |
Market Facts & Figures |
European Neurodegenerative Drugs Market: Competitor Market Share Scenario (in %) for 2019 & 2025 |
European Neurodegenerative Drugs Market Demand Scenario in US$ Million by Region/Country: 2018-2025 |
Neurodegenerative Drugs Market in Europe: A Historic Market Perspective in US$ Million by Region/Country for the Period 2009-2017 |
European Neurodegenerative Drugs Market Share Shift by Region/Country: 2009 VS 2019 VS 2025 |
European Neurodegenerative Drugs Market Estimates and Forecasts in US$ Million by Indication Drug: 2018-2025 |
Neurodegenerative Drugs Market in Europe in US$ Million by Indication Drug: A Historic Review for the Period 2009-2017 |
European Neurodegenerative Drugs Market Share Breakdown by Indication Drug: 2009 VS 2019 VS 2025 |
France |
Neurodegenerative Drugs Market in France by Indication Drug: Estimates and Projections in US$ Million for the Period 2018-2025 |
French Neurodegenerative Drugs Historic Market Scenario in US$ Million by Indication Drug: 2009-2017 |
French Neurodegenerative Drugs Market Share Analysis by Indication Drug: 2009 VS 2019 VS 2025 |
Germany |
Neurodegenerative Drugs Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Indication Drug for the Period 2018-2025 |
German Neurodegenerative Drugs Historic Market Analysis in US$ Million by Indication Drug: 2009-2017 |
German Neurodegenerative Drugs Market Share Breakdown by Indication Drug: 2009 VS 2019 VS 2025 |
Italy |
Italian Neurodegenerative Drugs Market Growth Prospects in US$ Million by Indication Drug for the Period 2018-2025 |
Neurodegenerative Drugs Historic Market Analysis in Italy in US$ Million by Indication Drug: 2009-2017 |
Italian Neurodegenerative Drugs Market by Indication Drug: Percentage Breakdown of Sales for 2009, 2019, and 2025 |
United Kingdom |
United Kingdom Market for Neurodegenerative Drugs: Annual Sales Estimates and Projections in US$ Million by Indication Drug for the Period 2018-2025 |
Neurodegenerative Drugs Market in the United Kingdom: Historic Sales Analysis in US$ Million by Indication Drug for the Period 2009-2017 |
United Kingdom Neurodegenerative Drugs Market Share Analysis by Indication Drug: 2009 VS 2019 VS 2025 |
Spain |
Spanish Neurodegenerative Drugs Market Estimates and Forecasts in US$ Million by Indication Drug: 2018 to 2025 |
Spanish Neurodegenerative Drugs Historic Market Review by Indication Drug in US$ Million: 2009-2017 |
Neurodegenerative Drugs Market in Spain: Percentage Share Breakdown of Sales by Indication Drug for 2009, 2019, and 2025 |
Russia |
Russian Neurodegenerative Drugs Market Estimates and Projections in US$ Million by Indication Drug: 2018 to 2025 |
Neurodegenerative Drugs Market in Russia by Indication Drug: A Historic Review in US$ Million for 2009-2017 |
Russian Neurodegenerative Drugs Market Share Breakdown by Indication Drug: 2009 VS 2019 VS 2025 |
Rest of Europe |
Rest of Europe Neurodegenerative Drugs Market Estimates and Forecasts in US$ Million by Indication Drug: 2018-2025 |
Neurodegenerative Drugs Market in Rest of Europe in US$ Million by Indication Drug: A Historic Review for the Period 2009-2017 |
Rest of Europe Neurodegenerative Drugs Market Share Breakdown by Indication Drug: 2009 VS 2019 VS 2025 |
Asia-Pacific |
Asia-Pacific Neurodegenerative Drugs Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025 |
Neurodegenerative Drugs Market in Asia-Pacific: Historic Market Analysis in US$ Million by Region/Country for the Period 2009-2017 |
Asia-Pacific Neurodegenerative Drugs Market Share Analysis by Region/Country: 2009 VS 2019 VS 2025 |
Neurodegenerative Drugs Market in Asia-Pacific by Indication Drug: Estimates and Projections in US$ Million for the Period 2018-2025 |
Asia-Pacific Neurodegenerative Drugs Historic Market Scenario in US$ Million by Indication Drug: 2009-2017 |
Asia-Pacific Neurodegenerative Drugs Market Share Analysis by Indication Drug: 2009 VS 2019 VS 2025 |
Australia |
Neurodegenerative Drugs Market in Australia: Recent Past, Current and Future Analysis in US$ Million by Indication Drug for the Period 2018-2025 |
Australian Neurodegenerative Drugs Historic Market Analysis in US$ Million by Indication Drug: 2009-2017 |
Australian Neurodegenerative Drugs Market Share Breakdown by Indication Drug: 2009 VS 2019 VS 2025 |
India |
Indian Neurodegenerative Drugs Market Estimates and Forecasts in US$ Million by Indication Drug: 2018 to 2025 |
Indian Neurodegenerative Drugs Historic Market Review by Indication Drug in US$ Million: 2009-2017 |
Neurodegenerative Drugs Market in India: Percentage Share Breakdown of Sales by Indication Drug for 2009, 2019, and 2025 |
South Korea |
Neurodegenerative Drugs Market in South Korea: Recent Past, Current and Future Analysis in US$ Million by Indication Drug for the Period 2018-2025 |
South Korean Neurodegenerative Drugs Historic Market Analysis in US$ Million by Indication Drug: 2009-2017 |
Neurodegenerative Drugs Market Share Distribution in South Korea by Indication Drug: 2009 VS 2019 VS 2025 |
Rest of Asia-Pacific |
Rest of Asia-Pacific Market for Neurodegenerative Drugs: Annual Sales Estimates and Projections in US$ Million by Indication Drug for the Period 2018-2025 |
Neurodegenerative Drugs Market in Rest of Asia-Pacific: Historic Sales Analysis in US$ Million by Indication Drug for the Period 2009-2017 |
Rest of Asia-Pacific Neurodegenerative Drugs Market Share Analysis by Indication Drug: 2009 VS 2019 VS 2025 |
Latin America |
Latin American Neurodegenerative Drugs Market Trends by Region/Country in US$ Million: 2018-2025 |
Neurodegenerative Drugs Market in Latin America in US$ Million by Region/Country: A Historic Perspective for the Period 2009-2017 |
Latin American Neurodegenerative Drugs Market Percentage Breakdown of Sales by Region/Country: 2009, 2019, and 2025 |
Latin American Neurodegenerative Drugs Market Growth Prospects in US$ Million by Indication Drug for the Period 2018-2025 |
Neurodegenerative Drugs Historic Market Analysis in Latin America in US$ Million by Indication Drug: 2009-2017 |
Latin American Neurodegenerative Drugs Market by Indication Drug: Percentage Breakdown of Sales for 2009, 2019, and 2025 |
Argentina |
Argentinean Neurodegenerative Drugs Market Estimates and Forecasts in US$ Million by Indication Drug: 2018-2025 |
Neurodegenerative Drugs Market in Argentina in US$ Million by Indication Drug: A Historic Review for the Period 2009-2017 |
Argentinean Neurodegenerative Drugs Market Share Breakdown by Indication Drug: 2009 VS 2019 VS 2025 |
Brazil |
Neurodegenerative Drugs Market in Brazil by Indication Drug: Estimates and Projections in US$ Million for the Period 2018-2025 |
Brazilian Neurodegenerative Drugs Historic Market Scenario in US$ Million by Indication Drug: 2009-2017 |
Brazilian Neurodegenerative Drugs Market Share Analysis by Indication Drug: 2009 VS 2019 VS 2025 |
Mexico |
Neurodegenerative Drugs Market in Mexico: Recent Past, Current and Future Analysis in US$ Million by Indication Drug for the Period 2018-2025 |
Mexican Neurodegenerative Drugs Historic Market Analysis in US$ Million by Indication Drug: 2009-2017 |
Mexican Neurodegenerative Drugs Market Share Breakdown by Indication Drug: 2009 VS 2019 VS 2025 |
Rest of Latin America |
Rest of Latin America Neurodegenerative Drugs Market Estimates and Projections in US$ Million by Indication Drug: 2018 to 2025 |
Neurodegenerative Drugs Market in Rest of Latin America by Indication Drug: A Historic Review in US$ Million for 2009-2017 |
Rest of Latin America Neurodegenerative Drugs Market Share Breakdown by Indication Drug: 2009 VS 2019 VS 2025 |
Middle East |
The Middle East Neurodegenerative Drugs Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025 |
Neurodegenerative Drugs Market in the Middle East by Region/Country in US$ Million: 2009-2017 |
The Middle East Neurodegenerative Drugs Market Share Breakdown by Region/Country: 2009, 2019, and 2025 |
The Middle East Neurodegenerative Drugs Market Estimates and Forecasts in US$ Million by Indication Drug: 2018 to 2025 |
The Middle East Neurodegenerative Drugs Historic Market by Indication Drug in US$ Million: 2009-2017 |
Neurodegenerative Drugs Market in the Middle East: Percentage Share Breakdown of Sales by Indication Drug for 2009, 2019, and 2025 |
Iran |
Iranian Market for Neurodegenerative Drugs: Annual Sales Estimates and Projections in US$ Million by Indication Drug for the Period 2018-2025 |
Neurodegenerative Drugs Market in Iran: Historic Sales Analysis in US$ Million by Indication Drug for the Period 2009-2017 |
Iranian Neurodegenerative Drugs Market Share Analysis by Indication Drug: 2009 VS 2019 VS 2025 |
Israel |
Israeli Neurodegenerative Drugs Market Estimates and Forecasts in US$ Million by Indication Drug: 2018-2025 |
Neurodegenerative Drugs Market in Israel in US$ Million by Indication Drug: A Historic Review for the Period 2009-2017 |
Israeli Neurodegenerative Drugs Market Share Breakdown by Indication Drug: 2009 VS 2019 VS 2025 |
Saudi Arabia |
Saudi Arabian Neurodegenerative Drugs Market Growth Prospects in US$ Million by Indication Drug for the Period 2018-2025 |
Neurodegenerative Drugs Historic Market Analysis in Saudi Arabia in US$ Million by Indication Drug: 2009-2017 |
Saudi Arabian Neurodegenerative Drugs Market by Indication Drug: Percentage Breakdown of Sales for 2009, 2019, and 2025 |
United Arab Emirates |
Neurodegenerative Drugs Market in the United Arab Emirates: Recent Past, Current and Future Analysis in US$ Million by Indication Drug for the Period 2018-2025 |
United Arab Emirates Neurodegenerative Drugs Historic Market Analysis in US$ Million by Indication Drug: 2009-2017 |
Neurodegenerative Drugs Market Share Distribution in United Arab Emirates by Indication Drug: 2009 VS 2019 VS 2025 |
Rest of Middle East |
Neurodegenerative Drugs Market in Rest of Middle East: Recent Past, Current and Future Analysis in US$ Million by Indication Drug for the Period 2018-2025 |
Rest of Middle East Neurodegenerative Drugs Historic Market Analysis in US$ Million by Indication Drug: 2009-2017 |
Rest of Middle East Neurodegenerative Drugs Market Share Breakdown by Indication Drug: 2009 VS 2019 VS 2025 |
Africa |
African Neurodegenerative Drugs Market Estimates and Projections in US$ Million by Indication Drug: 2018 to 2025 |
Neurodegenerative Drugs Market in Africa by Indication Drug: A Historic Review in US$ Million for 2009-2017 |
African Neurodegenerative Drugs Market Share Breakdown by Indication Drug: 2009 VS 2019 VS 2025 |
IV. COMPETITION |
Total Companies Profiled: 165 |